Cost of developing new drugs may be lower than industry claims: trial

Semaglutide retails for $17k USD/year in the US but costs only $60 to make. Perhaps it could be argued that the autoinjectors are "expensive", but not $17k/year and oral forms are coming online to make this item moot. In limited circumstances, excessive profits cross into the realm of price gouging and shouldn't be allowed by regulatory enforcement.

Microsoft Office retails for $250 but costs $0 to make. Perhaps it could be argued that installation CDs are "expensive", but not $250, and online downloads make this item moot.